Clinical practice with anti-dementia drugs: A revised (third) consensus statement from the British Association for Psychopharmacology
Clinical practice with anti-dementia drugs: A revised (third) consensus statement from the British Association for Psychopharmacology is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Clinical practice with anti-dementia drugs: A revised (third) consensus statement from the British Association for Psychopharmacology have?
Clinical practice with anti-dementia drugs: A revised (third) consensus statement from the British Association for Psychopharmacology has 355 citations in the OpenAlex counts ScholarIQ stores.
When was Clinical practice with anti-dementia drugs: A revised (third) consensus statement from the British Association for Psychopharmacology published?
Clinical practice with anti-dementia drugs: A revised (third) consensus statement from the British Association for Psychopharmacology has 2017 year in the ScholarIQ index.
What is the open-access status of Clinical practice with anti-dementia drugs: A revised (third) consensus statement from the British Association for Psychopharmacology?
Clinical practice with anti-dementia drugs: A revised (third) consensus statement from the British Association for Psychopharmacology has green oa status in the ScholarIQ index.
What is the DOI of Clinical practice with anti-dementia drugs: A revised (third) consensus statement from the British Association for Psychopharmacology?
The DOI for Clinical practice with anti-dementia drugs: A revised (third) consensus statement from the British Association for Psychopharmacology is on the source record.
What is the PMID of Clinical practice with anti-dementia drugs: A revised (third) consensus statement from the British Association for Psychopharmacology?
The PMID for Clinical practice with anti-dementia drugs: A revised (third) consensus statement from the British Association for Psychopharmacology is on the source record.
What is the OpenAlex record for Clinical practice with anti-dementia drugs: A revised (third) consensus statement from the British Association for Psychopharmacology?
The OpenAlex for Clinical practice with anti-dementia drugs: A revised (third) consensus statement from the British Association for Psychopharmacology is on the source record.